Prediabetes Drug Market: Epidemiology Landscape, Clinical Trials, and Market Outlook
Prediabetes has quietly become one of the most consequential public health challenges of our time, touching over a third of adults in the United States and more than a fifth of adults across Europe. Despite its scale, the prediabetes market remains largely undeveloped, with no drug yet carrying US FDA approval for this specific indication — leaving a wide gap between disease burden and...
0 Reacties 0 aandelen 846 Views 0 voorbeeld